Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:TCRR
Delisted

TCR2 Therapeutics Inc. Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$1.48
+0 (+0%)
At Close: Aug 30, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.48 $1.48 Wednesday, 30th Aug 2023 TCRR stock ended at $1.48. During the day the stock fluctuated 0% from a day low at $1.48 to a day high of $1.48.
90 days $1.48 $1.48
52 weeks $0.82 $2.87

Historical TCR2 Therapeutics Inc. prices

Date Open High Low Close Volume
Sep 02, 2021 $17.92 $18.15 $17.51 $17.78 591 291
Sep 01, 2021 $16.86 $17.81 $16.51 $17.54 489 377
Aug 31, 2021 $16.43 $16.82 $16.30 $16.77 290 161
Aug 30, 2021 $16.45 $16.82 $16.00 $16.38 312 757
Click to get the best stock tips daily for free!

About TCR2 Therapeutics Inc.

TCR2 Therapeutics. TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal... TCRR Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT